On May 5th, 2016 at MetLife Stadium, East Rutherford, NJ, 100s of CFOs and senior finance executives gathered at the 2016 CFO Innovation Conference and Awards hosted by CFO Studio.

BDO presented one discussion entitled, “Bio-tech and Pharma: Financing Growth, Evolving Customer Expectations,” which was moderated by New Jersey Office Managing Partner, Mark Giamo. The discussion was led by lead CFOs from the Biotechnology and Pharmaceutical field including: Barry Lederman, Chief Financial Officer of Halo Pharmaceutical; Andrew Einhorn, Chief Financial Officer of Edge Therapeutics; Jim Mastakas, Senior Vice President and Chief Financial Officer of Amneal Pharmaceuticals; and Brian Zietsman, President and Chief Financial Officer of Enteris BioPharma. They discussed their experiences and expectations, and the demands and opportunities of their roles as CFOs in pharmaceutical and biotechnology companies.

Business development partners for this event included Bank of America Merrill Lynch, JLL, BC Compliance Group, Robert Half, Yorktel, PwC, WithumSmith+Brown, Fulton Bank of New Jersey, TD Bank, SAP, BDO, Tahas Technologies, Alliance Cost Containment, Dun & Bradstreet, Reed Smith, McCarter & English, Theorem, and PKF O’Connor Davies.

To find out more about this event, such as the recipients of our 2016 CFO Innovation Awards, please visit www.cfoinnovationconference.com. To view more of our upcoming events you may visit www.cfostudio.com. You could also download our recently launched CFO Studio App, available for Apple and Android.